| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/JID.2013.471 |
| P698 | PubMed publication ID | 24213373 |
| P50 | author | Anfernee Kai-Wing Tse | Q84010094 |
| Wang Fun Fong | Q114413151 | ||
| Hiu Yee Kwan | Q57320304 | ||
| Brian Chi-Yan Cheng | Q61156883 | ||
| P2093 | author name string | Hua Yu | |
| Zhi-Ling Yu | |||
| Hui-Hui Cao | |||
| P2860 | cites work | CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells | Q24301679 |
| Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation | Q24337533 | ||
| Cyclooxygenase in biology and disease | Q27863453 | ||
| Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation | Q28171193 | ||
| An antagonist decoy receptor and a death domain-containing receptor for TRAIL | Q28245153 | ||
| KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene | Q28250929 | ||
| General Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC | Q28385542 | ||
| NSAIDs enhance proteasomic degradation of survivin, a mechanism of gastric epithelial cell injury and apoptosis | Q28576014 | ||
| Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1,25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling | Q33746077 | ||
| Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins | Q33780727 | ||
| Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. | Q34006269 | ||
| Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. | Q34086453 | ||
| Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis | Q80210089 | ||
| Potentiation of doxorubicin-induced apoptosis and differentiation by indomethacin in K-562 leukemia cells | Q80342334 | ||
| Utilization of the cellular stress response to sensitize cancer cells to TRAIL-mediated apoptosis | Q34286028 | ||
| ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins | Q34496536 | ||
| Death receptors and melanoma resistance to apoptosis | Q35146582 | ||
| On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics | Q35853714 | ||
| Mechanisms of resistance to TRAIL-induced apoptosis in cancer | Q35954258 | ||
| Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors | Q37063421 | ||
| TRAIL receptor signaling and therapeutics. | Q37785559 | ||
| The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS). | Q38007570 | ||
| New therapeutical strategies in the treatment of metastatic disease. | Q38050461 | ||
| Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2. | Q38114116 | ||
| Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. | Q38295218 | ||
| Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROS-dependent ER-stress | Q38470598 | ||
| In the Huh7 Hepatoma Cells Diclofenac and Indomethacin Activate Differently the Unfolded Protein Response and Induce ER Stress Apoptosis | Q38586382 | ||
| Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax | Q39205142 | ||
| A 71-gene signature of TRAIL sensitivity in cancer cells. | Q39452724 | ||
| Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand | Q39455873 | ||
| Sensitization of melanoma cells for death ligand-induced apoptosis by an indirubin derivative—Enhancement of both extrinsic and intrinsic apoptosis pathways | Q39653145 | ||
| Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP. | Q39726376 | ||
| Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity | Q39876548 | ||
| Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response. | Q39938693 | ||
| Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. | Q40029467 | ||
| IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin | Q40035487 | ||
| Indomethacin enhances the cytotoxicity of recombinant human lymphotoxin alpha on tumor cells by suppressing NFkappaB signaling | Q40079828 | ||
| Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4. | Q40198109 | ||
| Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). | Q40349901 | ||
| Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation | Q40369516 | ||
| Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax. | Q40454759 | ||
| Pseudomonas aeruginosa lipopolysaccharide induction of keratinocyte proliferation, NF-kappa B, and cyclin D1 is inhibited by indomethacin. | Q40455039 | ||
| Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis | Q40558204 | ||
| Translational control of tumor necrosis factor-related apoptosis-inducing ligand death receptor expression in melanoma cells | Q40605290 | ||
| Radiation induced G1-block and p53 status in six human cell lines | Q41288130 | ||
| Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. | Q42487048 | ||
| Survivin: a novel target for indomethacin-induced gastric injury | Q45212243 | ||
| Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis | Q47670151 | ||
| RAF inhibition overcomes resistance to TRAIL-induced apoptosis in melanoma cells | Q47755290 | ||
| Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis. | Q53857642 | ||
| Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. | Q54013066 | ||
| Cure of B16F10 melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: characteristics of killer cells generated in situ. | Q54388132 | ||
| Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor–related apoptosis-inducing ligand | Q56876469 | ||
| Cutaneous Malignant Melanoma | Q62888189 | ||
| Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells | Q77319256 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1397-1407 | |
| P577 | publication date | 2013-11-08 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin | |
| P478 | volume | 134 |
| Q33574636 | Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo |
| Q38964395 | Decitabine and SAHA-induced apoptosis is accompanied by survivin downregulation and potentiated by ATRA in p53-deficient cells |
| Q92733813 | Endoplasmic Reticulum Stress Contributes to Indomethacin-Induced Glioma Apoptosis |
| Q41898583 | Icariside II overcomes TRAIL resistance of melanoma cells through ROS-mediated downregulation of STAT3/cFLIP signaling |
| Q53706352 | Indomethacin Disrupts Autophagic Flux by Inducing Lysosomal Dysfunction in Gastric Cancer Cells and Increases Their Sensitivity to Cytotoxic Drugs. |
| Q52730975 | Indomethacin induced glioma apoptosis involving ceramide signals. |
| Q87681067 | Indomethacin to the rescue of TRAIL-resistant melanomas |
| Q33780055 | Inhibiting STAT3 signaling is involved in the anti-melanoma effects of a herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos |
| Q38735379 | Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer |
| Q34461177 | Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer |
| Q87681079 | JID VisualDx quiz: May 2014 |
| Q44959749 | Management of intracranial melanomas in the era of precision medicine |
| Q46249392 | Matrine-Type Alkaloids Inhibit Advanced Glycation End Products Induced Reactive Oxygen Species-Mediated Apoptosis of Aortic Endothelial Cells In Vivo and In Vitro by Targeting MKK3 and p38MAPK Signaling |
| Q60951251 | Mycelia Exert Anti-liver Cancer Effects and Inhibit STAT3 Signaling and |
| Q40775748 | Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins |
| Q37594798 | Sensitization of melanoma cells to alkylating agent-induced DNA damage and cell death via orchestrating oxidative stress and IKKβ inhibition |
| Q28548386 | TRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress Response |
| Q55069085 | [What's new in skin cancers?]. |
Search more.